Variation in Activities of Non-Plasmin Fibrinolytic Proteinase and Plasminogen-Activator in the Lung and Spleen Induced by Bacterial Endotoxin in Rats with Special Reference to the Effects of MD-805

Summary

The behavior of direct fibrinolytic (non-plasmin) proteinase activity and plasminogen-activator activity in the lung and spleen was investigated in rats after a single intravenous injection of bacterial endotoxin, and the influence of thrombin inhibitors on the effects of the endotoxin was assessed.

The non-plasmin fibrinolytic activitiy was markedly increased following a decrease of plasminogen-activator in the lung. In addition, variations in hematological parameters, i.e. a decrease of platelet count, fibrinogen level and antithrombin III, and an increase of blood urea nitrogen and euglobulin fibrinolytic activity, were induced by the injection, indicating the occurrence of disseminated intravascular coagulation.

In comparative studies on the effects of the endotoxin injection and thrombin infusion, in the lung and spleen an increase of fibrinolytic proteinase activity was induced in a similar manner; the plasminogen-activator activity in the lung was decreased by the endotoxin injection but not decreased by the thrombin infusion.

In prevention studies with heparin and MD-805, the latter was found to prevent the decrease of either fibrinogen or platelet count. However, the former failed to prevent the decrease of platelet count although that of the fibrinogen level was prevented. Heparin and MD-805 exerted no preventive effect on the endotoxin-induced variations of proteinase activity and plasminogen-activator activity in the lung.

Keywords

Non-plasmin fibrinolytic proteinase - Plasminogen-activator - Endotoxin - MD-805 - Synthetic thrombin inhibitor

• References

• 1 Okamoto U, Yamamoto J, Nagamatsu Y, Horie N. Fibrinolytic activity of lung and spleen extracts observed in conventional but not in germfree rats. Thromb Haemostas 1979; 42: 726-733
• 2 Sakakibara B, Okamoto U, Ikeda M, Yamamoto J, Hosotani T, Horie N, Kazumasu K, Nagamatsu Y, Higashi T, Uno H. Wound healing in germfree animals (II). J Germfree Life Gnotobiology 1976; 6: 36-39
• 3 Okamoto S, Hijikata A, Kikumoto R, Tamao Y. A synthetic thrombin inhibitor taking extremely active stereo-structures. Thromb Haemostas 1979; 42: 205
• 4 Okamoto S, Hijikata A, Kikumoto R, Tonomura S, Hara H, Ninomiya K, Maruyama A, Sugano M, Tamao Y. Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. The importance of stereostructure of its hydrophobic carboxamide portion Biochem Biophys Res Commun 1981; 101: 440-446
• 5 Quick AJ. Quantitative estimation of fibrinogen. Hemorrhagic disease. Lea and Febiger; Philadelphia: 1957. pp 436-439
• 6 Brecher G, Cronkite EP. Morphology and enumeration of human blood platelets. J Appl Physiol 1950; 3: 365-377
• 7 Gallimore MJ, Tyler HM, Shaw JT B. The measurement of fibrinolysis in the rat. Thrombos Diathes Haemorrh 1971; 26: 295-310
• 8 Hattersley PG, Hayse D. The effect of increased contact activation on the activated partial thromboplastin time. Am J Clin Pathol 1976; 66: 479-482
• 9 Gutmann I, Bergmeyer HV. Urea. Method of Enzymatic Analysis, 2nd English ed. Verlag Chemie, Weinheim and Academic Press; New York and London: 1974. pp 1791-1801
• 10 Hawiger J, Niewiarowski S, Gurewick V, Thomas DP. Measurement of fibrinogen and fibrin degradation product in serum by staphylococcal clumping test. J Lab Clin Med 1970; 75: 93-108
• 11 Ødegård OR, Lie M, Abildgaard U. Heparin cofactor activity measured with an amidolytic method. Thromb Res 1975; 6: 287-294
• 12 Ødegård OR. Evaluation of an amidolytic heparin cofactor assay method. Thromb Res 1975; 7: 351-360
• 13 Astrup T, Stemdorff I. The plasminogen activator in animal tissue. Acta Physiol Scand 1956; 36: 250-255
• 14 Oshiba S, Okamoto S. Influence of AMCHA on the activity of fibrinolysin (plasmin). Keio J Med 1962; 11: 117-125
• 15 Rijken DC, Collen D. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J Biol Chem 1981; 256: 7035-7041
• 16 Wong TC. A study on the generalized Schwartzman reaction in pregnant rats induced by bacterial endotoxin. Am J Obstet Gynecol 1962; 15: 786-797
• 17 Schoendorf HT, Rosenberg M, Beller FK. Endotoxin-induced disseminated intravascular coagulation in nonpregnant rats. Am J Pathol 1971; 65: 51-58
• 18 Theiss W, Beller FK. The effect of saline loading on endotoxin induced disseminated intravascular coagulation. J Lab Clin Med 1973; 81: 431-442
• 19 Theiss W, Hilgard P, Heyes H. Induction of disseminated intravascular coagulation by endotoxin and saline loading in rats. II. Fibrin deposition and removal. Thromb Res 1975; 7: 47-58
• 20 Morrison DC, Ulevitch RJ. The effects of bacterial endotoxins on host mediation systems. Am J Pathol 1978; 93: 527-601
• 21 Saldeen T. The disappearance of fibrin from the pulmonary vessels in experimental fat embolism. Thrombos Diathes Haemorrh 1969; 22: 360-371
• 22 Egberg N, Nordström S. Effects of reptilase-induced intravascular coagulation in dogs. Acta Physiol Scand 1970; 79: 493-505
• 23 Coombey D, Tyler HM. Quantitative monitoring of intravascular coagulation and fibrinolysis in the lungs of rats. Thrombos Diathes Haemorrh 1972; 27: 241-245
• 24 Bagge L, Busch C, Rammer L, Saldeen T. Delayed fibrin elimination from the lungs of burned rats with endogeneous inhibition of the fibrinolytic system. Thromb Res 1973; 2: 365-376
• 25 Busch C, Rammer L, Saldeen T. Quantitation of fibrin deposition and elimination in organs of rats injected with labelled fibrinogen and albumin. Thrombos Diathes Haemorrh 1973; 29: 94-107
• 26 Sherman LA. Catabolism of fibrinogen and its derivatives. Thromb Haemostas 1977; 38: 809-822
• 27 Carlin G, Einarsson M, Saldeen T. Delayed elimination of fibrin from the lungs in rats given α₂-antiplasmin. Thromb Haemostas 1981; 46: 757-758
• 28 Hara H, Tamao Y, Kikumoto R, Funahara Y, Hijikata A, Okamoto S. Effect of a potent thrombin inhibitor, No 407 on platelet function in vitro and in vivo. Kobe J Med Sci 1980; 26: 47-60
• 29 Kumada T, Abiko Y. Comparative study on heparin and a synthetic thrombin inhibitor No 805 (MD 805) in experimental antithrombin III deficient animals. Thromb Res 1981; 24: 285-298